This page provides Regulatory news filings submitted by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.

Hamilton, Bermuda:  November 3, 2023 – Horizon Therapeutics Treasury DAC (the “Company”) has advised the Bermuda Stock Exchange (the BSX) of the maturity and redemption of the following securities listed on the BSX:

 

·         Horizon Therapeutics Treasury DAC Tranche 1 - 3.28% Promissory Note Due 20 May, 2026

·         Horizon Therapeutics Treasury DAC Tranche 2 - 8.1% Promissory Note Due 20 May, 2026

 

The de-listing of the securities from the BSX pursuant to the provisions of the BSX Listing Regulations, Section I, Chapter 2, Regulation 2.33 is effective today, November 3, 2022.

 

                       

# # # #

 

About BSX

The Bermuda Stock Exchange (BSX), a wholly owned subsidiary of Miami International Holdings, Inc., is a fully electronic, vertically integrated international securities market headquartered in Bermuda and organised in 1971. BSX specialises in the listing and trading of capital market instruments such as equities, debt issues, funds, hedge funds, derivative warrants, and insurance linked securities. To learn more about BSX visit https://www.bsx.com or contact info@bsx.com